Agenus maintains a global footprint by way of collaborations and partnerships with foremost pharmaceutical and biotechnology firms in North The united states, Europe and Asia. Its agreements contain study and advancement collaborations, license arrangements and co-progress programs geared toward accelerating the translation of novel immunotherapies